Clinical Trial Update: A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis [Phase 2]

View source ↗

Summary

This update reports the Phase 2 long-term safety results for MEDI-545 in adults with Systemic Lupus Erythematosus or Myositis. The study has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myositis
• Systemic Lupus Erythematosus

Drugs mentioned

• MEDI-545

Snippet

Sponsor: MedImmune LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2016-08-23